Administration of silver sulfadiazine and radioactive derivative

Details Administration of silver sulfadiazine and radioactive derivative Administration of silver sulfadiazine and radioactive derivative

1974-12-19

1977-04-26

Padgett, Benjamin R.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Molecular bilayer structure

424228, 424290, A61K 4300, A61K 3163, A61L 1300

Patent

active

040201503

ABSTRACT:
Silver sulfadiazine has been found to be therapeutically useful when administered orally or subcutaneously in doses not exceeding 1,050 mg/kg. It also has been found that radioactive derivatives of silver sulfadiazine localize in tumors, the resultant radiation within the region of the tumor serving to eradicate malignant cells.

REFERENCES:
patent: 2422688 (1947-06-01), Lott
patent: 3761590 (1973-09-01), Fox, Jr.
Sandman et al, Journal of Pharmaceutical Sciences, vol. 63, No. 6, June, 1974, pp. 948-951.

Affiliated with

Also associated with

Rating

Administration of silver sulfadiazine and radioactive derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Administration of silver sulfadiazine and radioactive derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of silver sulfadiazine and radioactive derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2087569